Finding the right ceftriaxone dose for pneumonia
Part of Infections, Lungs & breathing clinical trials.
This study compares different doses of ceftriaxone (a common antibiotic) to see which dose works best for treating pneumonia in patients who are not critically ill. The goal is to help doctors prescribe the most effective and safe dose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were seen in an emergency department or admitted to the hospital within the past 72 hours
- You have been diagnosed with community-acquired pneumonia (pneumonia caught outside of a hospital)
- Your doctor has prescribed ceftriaxone (an antibiotic) to treat your pneumonia
- You are not currently in or planned to go to an intensive care unit (ICU)
- You are not experiencing severe breathing problems requiring a breathing machine or strong oxygen support
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving antibiotics directly into the lungs can help treat severe pneumonia. If you have been hospitalized with pneumonia and have a high fever or high inflammation levels, you may be eligible.
This trial compares different antibiotic strategies for children with pneumonia who are being treated as outpatients. The goal is to find the best approach to treat the infection and help your child recover.
This trial tests if adjusting ceftazidime (a powerful antibiotic) early on helps treat serious infections better in intensive care patients. You may qualify if you are in the ICU and your doctor is considering starting this antibiotic.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial tests if the antibiotic ceftriaxone can prevent early pneumonia in patients on breathing machines after a serious brain injury.
This trial tests whether an oral antibiotic (amoxicillin) works as well as an IV antibiotic (ceftriaxone) for children with mild pneumonia. It may help avoid the need for an IV line.
Hear when a new Community Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.